Pakistan, Qatar explore new avenues for trade, investment cooperationPublished on: October 26, 2026 10:02 AM

Pakistan, Oct. 26 -- Federal Minister for Commerce Jam Kamal Khan and Qatar's Minister of State for Foreign Trade Affairs Dr. Ahmad bin Mohammed Al-Sayed co-chaired the second meeting of the Pakistan-... Read More

JEE Main Session 1 Exam 2027: NTA introduces Meri Pehchaan platform for registration, direct link to apply here

India, Oct. 26 -- The National Testing Agency, NTA has started the registration process for JEE Main Session 1 Exam 2027. Candidates who want to appear for Joint Entrance Examination can check the dir... Read More

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy Versus Physician’s Choice of Chemotherapy in Participants With B7-H4-selected Advanced/Metastatic Endometrial Cancer Who Progressed on or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Jio Platforms IPO Allotment 2026: When Will Allotment Status Be Announced? Check Date, Expected Time, How to Verify Shares on NSE, BSE and KFinTech, and When Will Shares Be Credited?

India, Oct. 26 -- Investors awaiting the outcome of the Jio Platforms initial public offering (IPO) can check their allotment status on Monday, October 26, 2026, with the basis of allotment expected t... Read More

Prolapse is common after pregnancy and later in life. Here's what to look out for

India, Oct. 26 -- Prolapse is common after pregnancy and later in life. Here's what to look out for The pelvic floor is a layer of muscles and connective tissues that supports the uterus, bladder, ur... Read More

Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 26 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More

• ««
• «
• 1435
• 1436
• 1437
• 1438
• 1439
• 1440
• 1441
• 1442
• 1443
• 1444
• »
• »»